Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systematic literature review of the epidemiology of neurotrophic tyrosine receptor kinase positive solid tumor sites.

Future oncology (London, England) - 1 May 2025

Villacorta Reginald, Gallagher-Colombo Shannon, Lahiji Armin, Myers Sky, Briggs Jonathon, Phalguni Angaja

Abstract excerpt

AIMS: This study aimed to expand on existing systematic literature reviews (SLRs) by assessing the prevalence of neurotrophic tyrosine receptor kinase (NTRK) fusion-positive mutations across solid tumors in adult U.S populations. It further evaluated incidence, testing, treatment, mortality, and progression rates by tumor type, extending evidence through 2023. MATERIALS & METHODS: A SLR was conducted following...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Indazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogene Proteins, Fusion

Share to Protein Kinase Inhibitors

Share to Pyrazoles

Share to Pyrimidines

Share to Receptor Protein-Tyrosine Kinases

Share to Receptor, trkA

Source

Open in PubMed Open full text

Identifiers

PMID: 40152538
DOI: 10.1080/14796694.2025.2481022
PMCID: PMC12051583

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systematic literature review of the epidemiology of neurotrophic tyrosine receptor kinase positive solid tumor sites.PMID 40152538Read ↗

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in AdultsSemantic proximity Read ↗

NTRK1-3 Fusions in Sarcomas: Prevalence, Significance, and Clinical Implications – A Systematic ReviewSemantic proximity Read ↗

Prevalence of neurotrophic tropomyosin receptor kinase ( NTRK ) fusion gene positivity in patients with solid tumors in JapanSemantic proximity Read ↗

Prevalence and clinico-genomic characteristics of patients with TRK fusion cancer in ChinaSemantic proximity Read ↗

Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancerSemantic proximity Read ↗

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationSemantic proximity Read ↗

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in ChinaSemantic proximity Read ↗

Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSemantic proximity Read ↗

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinibSemantic proximity Read ↗

NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy TargetSemantic proximity Read ↗

Testing algorithm for identification of patients with TRK fusion cancerSemantic proximity Read ↗

Current management of neurotrophic receptor tyrosine kinase fusion-positive sarcoma: an updated reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.